VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A165-induced disturbances of barriers formed by retinal endothelial cells or long-term cultivated ARPE-19 cells - Deissler, H L; Stutzer, J N; Lang, G K (Exp Eye Res, 2020)